The invention relates to 2-aminobenzimidazoles useful in treating disorders that are mediated by A
2a
receptor function, including neurodegenerative diseases including Parkinson's disease and inflammation. The compounds have general formula I:
这项发明涉及对通过A2A受体功能介导的疾病进行治疗的
2-氨基苯并咪唑类化合物,包括帕
金森病和炎症等神经退行性疾病。这些化合物的一般式为I: